Abstract
While there is a wealth of literature on the impact of urban design on health, our understanding of the factors that influence integration of health into urban design is limited. With the growing recognition of cities playing a leading role in enhancing health equity and population health outcomes, there is a need to examine the perspectives and experiences of municipal actors around health and equity. To address this gap, we interviewed 30 stakeholders engaged with urban design policy- and decision-making at the City of Regina in Saskatchewan, Canada. We found a lack of shared understanding of health among municipal actors. Our findings identified a number of factors that serve as facilitators and barriers to integrating health and equity in urban design policies. Findings from this case study deepen our understanding of these factors and provide recommendations for developing healthy urban design policies. Our findings underscore the importance of adopting an integrated and holistic approach for healthy and equitable urban design. As urbanisation continues to bring a greater share of the world’s population into urban areas, it is imperative that we deepen our understanding of how municipal governance can be leveraged to create environments that are conducive to the wellbeing of their residents.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Saskatchewan Health Research Foundation [grant number 6470, 2023]
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for this research was received from the University of Regina Research Ethics Board (project ID: 2023-109).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
CRediT authorship contribution statement: Akram Mahani: Funding Acquisition, Conceptualization, Data Collection, Methodology, Project Management, Writing, Review and Editing, Supervision
Joonsoo Sean Lyeo: Data Analysis, Literature Review, Writing the First Draft of Manuscript, Editing and Revising Different Drafts of Manuscript
Agnes Fung: Data Analysis, Preparing Tables & Figure, Contribution to Manuscript Writing
Kelly Husack, Nazeem Muhajarine, Tania Diener, Chelsea Brown: Conceptualization, Reviewing and Contextualizing Research Findings, Reviewing and Commenting on Different Drafts of Manuscript
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Data availability: The data that has been used is confidential.
Funding: This work was supported by the Saskatchewan Health Research Foundation [grant number 6470, 2023].
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.